drug targeting – TechConnect Briefs

Anticancer Iron Oxide Nanoparticles

Benyettou F., Lalatonne Y., Sainte-Catherine O., Lecouvey M., Motte L., Laboratoire CSPBAT FRE 3043 CNRS, FR

We designed a new therapeutic nanoplatform which could be both imaged in situ with MRI (T2 contrast agent) and/or addressed by magnetic targeting (magnet) or specific molecules (peptides, antibodies …). The biological in-vitro tests performed [...]

The Austrian NANO Initiative: Small Country with Strong Expertise

Haas M., Glenck E., Austrian Research Promotion Agency (FFG), AT

The Austrian NANO Initiative is the multi-annual public funding programme for nanoscale sciences and nanotechnology. It coordinates different action lines at national and regional levels. The Austrian Research and Promotion Agency (FFG) runs the programme [...]

Peptidic Nanoparticles for Cancer Therapy and Diagnosis

Graff A., Tropel D., Raman SK., Machaidze G., Lustig A., Burkhard P., University of Basel, CH

Somatostatin peptides such as somatostatin 28 or 14 are known for their high binding affinity to G-coupled peptide receptors, which are often over-expressed on tumor cells. Using this binding property we developed a new type [...]